Arcade Therapeutics Accepted to the February 2025 Cohort for the Innovations in Mental Health Immersion Programme

New York, NY (February 4, 2025) – Arcade Therapeutics has been accepted into the Innovations in Mental Health Immersion Programme. This prestigious 12-week program is dedicated to supporting startups that address mental health challenges such as depression, anxiety, and psychosis through innovative digital solutions.

This program, led by KHP Ventures (a partnership between King’s College London and major NHS hospital trusts), allows a globally diverse group of companies to connect with leading innovators in the UK and take steps towards integrating with the National Health Service.

As the digital health industry continues to evolve, we are thrilled to be part of a community that shares our commitment to advancing mental health care through cutting-edge technology. Admission into this program will help accelerate our efforts to bring impactful, accessible, and effective therapeutic tools to even more people in need.

“Mental health is a global challenge, and the need requires global partners to come together with solutions. That’s why I’m so excited for Arcade Therapeutics to be part of this program” said Raj Amin, Co-Founder and CEO of Arcade Therapeutics. “As the digital health industry continues to evolve, we are thrilled to be part of a community that shares our commitment to advancing mental health care through cutting-edge technology. Admission into this program will help accelerate our efforts to bring impactful, accessible, and effective therapeutic tools to even more people in need.”

More information about this program can be found here. 

About Arcade Therapeutics
Arcade Therapeutics is a science-first game studio dedicated to treating mental illness by combining the most cutting edge cognitive neuroscience with engaging games. Arcade’s mission is to radically transform the mental health journey through highly accessible, clinically validated therapeutic games. Its NYC-based team includes leaders in clinical research, consumer products, game development, and healthcare strategy. To learn more visit https://arcadetherapeutics.com/.

About KHP Ventures
KHP Ventures is a collaboration between King’s College London, King’s College Hospital NHS Foundation Trust and Guy’s and St Thomas’ Hospital NHS Foundation Trust. Their vision is to support a world-leading healthcare ecosystem that drives new frontiers in modern medicine with synergistic integration of healthcare, academia, innovation and private capital. KHP Ventures launched the first NHS-anchored venture fund in 2021, investing in clinical innovators and enabling adoption of transformative solutions at scale. To learn more, visit https://khpventures.com/

***END***